Hims & Hers officer plans sale of 29,277 shares
Officer Okupe Oluyemi has filed a Rule 144 notice to sell 29,277 Hims & Hers Class A shares previously acquired via options and restricted stock vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. (HIMS) is the issuer referenced in a notice under Rule 144 for a proposed sale of 29,277 shares of Class A common stock for the account of officer Okupe Oluyemi. The filing lists an aggregate market value of $876,846.15 for these shares and notes 224,935,790 Class A shares outstanding as of September 22, 2026.
The shares to be sold were acquired through a stock option exercise of 14,000 shares and multiple restricted stock vestings between March 15, 2025 and August 15, 2026. The document also reports a prior sale of 12,313 Class A shares for $354,860.66 on June 17, 2026 under Rule 144 aggregation requirements.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise financial
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing mean for HIMS?
AI-generated analysis. How Rhea-AI works. Not financial advice.